TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Nordic Bioscience A/S
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
236,409
|
313,570
|
271,014 |
Earnings before taxes |
43,008
|
138,108
|
127,490 |
Total assets |
291,155
|
271,867
|
265,898 |
Current assets |
204,369
|
187,355
|
188,179 |
Current liabilities |
186,470
|
155,053
|
101,995 |
Equity capital |
61,597
|
71,667
|
117,731 |
- share capital |
10,000
![]() |
10,000
![]() |
10,000 |
Employees (average) |
150
![]() |
150
![]() |
150 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
21.2%
|
26.4%
|
44.3% |
Turnover per employee |
1,576
|
2,090
|
1,807 |
Profit as a percentage of turnover |
18.2%
|
44.0%
|
47.0% |
Return on assets (ROA) | |||
Current ratio |
109.6%
|
120.8%
|
184.5% |
Return on equity (ROE) |
69.8%
|
192.7%
|
108.3% |
Change turnover |
-77,161
|
42,556
|
271,014 |
Change turnover % |
-25%
|
16% | |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.